Results 281 to 290 of about 87,970 (343)

Myelin Formation by Oligodendrocytes Is Enhanced Through Laminin‐411 and Its Derived Peptide

open access: yesGlia, Volume 73, Issue 8, Page 1692-1706, August 2025.
Main Points Laminin (LM) α1, α2, and α4 chains are expressed at the myelination stage of oligodendrocyte (OL). LM411 and its E8 fragment enhance OL myelin membrane formation. A4G47 from LM411E8 is a novel peptide that promotes OL myelin formation. ABSTRACT In the central nervous system, oligodendrocytes (OLs) form myelin sheaths that accomplish the ...
Binri Sasaki   +14 more
wiley   +1 more source

The Role of Interleukin‐23 and Interleukin‐17 in Peri‐Implant Crevicular Fluid of Subjects With Peri‐Implant Disease: A Systematic Review

open access: yesJournal of Clinical Laboratory Analysis, Volume 39, Issue 15, August 2025.
The role of IL‐23/IL‐17 cytokine axis in peri‐implant disease. ABSTRACT Background Activation of the IL‐23/IL‐17 cytokine axis could trigger peri‐implant bone loss. The aim of this review was to analyze whether in people with peri‐implantitis (PI) and peri‐implant mucositis (PM) the concentrations of the interleukin‐23 and interleukin‐17 in peri ...
Mario Alberto Alarcón‐Sánchez   +5 more
wiley   +1 more source

An Elastase Inhibitor ShSPI from Centipede Attenuates Bleomycin-Induced Pulmonary Fibrosis. [PDF]

open access: yesToxins (Basel)
Lian X   +7 more
europepmc   +1 more source

Polypharmacology‐Driven Discovery of ZAK‐I‐57: A Potent Multi‐Targeted Benzoxazinone Small Molecule for Hepatocellular Carcinoma Therapy

open access: yesMedComm, Volume 6, Issue 8, August 2025.
ABSTRACT Hepatocellular carcinoma (HCC) is a deadly disease characterized by a high mortality rate and resistance to conventional therapies, highlighting the need for novel therapeutic interventions. Given the multifaceted nature of HCC pathogenesis, a multitargeted and polypharmacological approach is crucial for effective treatment. This study reports
Shakeel Ahmad Khan   +4 more
wiley   +1 more source

Evolving nutrition therapy in cystic fibrosis: Adapting to the CFTR modulator era

open access: yesNutrition in Clinical Practice, Volume 40, Issue 4, Page 816-828, August 2025.
Abstract Cystic fibrosis transmembrane regulator (CFTR)–directed therapies, such as modulators, have transformed the medical management of people with CF, resulting in better lung function, weight, and body mass index in recent years. With improved nutrition status in people on CFTR modulators, the emphasis on a high‐energy, high‐fat diet (the legacy ...
Kay Vavrina   +5 more
wiley   +1 more source

Screening of a Plant Extract Library from the Greek Flora for Biological Activities Related to Anti-Aging Applications. [PDF]

open access: yesAntioxidants (Basel)
Pratsinis H   +21 more
europepmc   +1 more source

Cold Atmospheric Plasma for Water Disinfection: Mechanisms, Efficacy and Resistant Bacteria Inactivation

open access: yesPlasma Processes and Polymers, Volume 22, Issue 8, August 2025.
Cold atmospheric plasma (CAP) is a promising method for inactivating antibiotic‐resistant bacteria in liquid environments. This review explores its mechanisms, treatment parameters, and efficacy, highlighting CAP's potential as a sustainable, resistance‐free disinfection alternative and its relevance for advancing water treatment and combating ...
Manca Lunder, Sebastian Dahle, Rok Fink
wiley   +1 more source

Cystic Fibrosis Year in Review 2024

open access: yesPediatric Pulmonology, Volume 60, Issue 8, August 2025.
ABSTRACT In 2024, important advances for people with cystic fibrosis (CF) were published. Important guidelines for newborn screening and care of infants diagnosed with CF transmembrane conductance regulator (CFTR)‐Related Metabolic Syndrome/Cystic Fibrosis Screen Positive Inconclusive Diagnosis (CRMS/CFSPID) were published alongside related key lessons
Adrienne P. Savant
wiley   +1 more source

Home - About - Disclaimer - Privacy